Archives

by in
Entry Author Date Location
ProNAi Therapeutics Closes on $59.5M to Advance Cancer Drug 04/22/14 Detroit
Gates Foundation Hires Second Biotech VC to Connect With Startups 02/18/14 Seattle
PowerVision Receives $20,000,000 Series D Funding 01/28/14 San Francisco
Gates Foundation Health Chief on Coaxing Pharma to Do Good (Part 2) 11/26/13 National
Frazier Healthcare Adds Carol Gallagher as Venture Partner 10/29/13 San Francisco
Profiles in Perseverance: Building Biotechs to Last. Coming Dec. 9 10/18/13 San Francisco
Gates Foundation Lures Biotech VC to Work on Global Health Startups 08/13/13 Seattle
East Coast Life Sciences Roundup: Sarepta, Agios, Gerngross, & (Much) More 07/26/13 Boston
Alcresta Secures $10,000,000 Series B Financing 07/22/13 Boston
Silvergate Pharmaceuticals Secures $23,554,167 New Funding 06/17/13 Detroit
Glaukos Obtains $30,000,000 Series F Funding 02/08/13 San Diego
If You’ve Got a Real Breakthrough, the FDA Wants To Talk 01/14/13 National
Abode Healthcare Receives $10,000,000 New Funding 12/31/12 Boulder/Denver
Digging in the Closet for Halloween? Get Out Your Icos Mementos 10/30/12 Seattle
Who Will Survive the Biotech VC Downturn? The Young and the Proven 10/22/12 National
Which VCs Are Poised to Cash In On the Biotech IPOs of 2012? 10/15/12 National
Exclusive: OVP Venture Partners, NW’s Oldest VC Firm, To Shut Down 10/11/12 Seattle
Celgene Puts $35M into VentiRx, Gets Option to Buy Cancer Drugmaker 10/03/12 Seattle
Join Cliff Stocks, Pat Gray, Mike Gallatin & More Nov. 27 for ‘The Icos Impact’ 09/20/12 Seattle
Cardiac Dimensions Nabs $5.8M for Heart Failure Device 09/12/12 Seattle
Atterocor Lands $16M Series A Round For Cancer Therapy 08/07/12 Detroit
Atterocor Receives $16,000,000 Series A Financing Round 08/06/12 Detroit
Frazier Makes It Official: Seeking to Raise New $400M Fund 07/03/12 Seattle
Abode Healthcare Secures $13,100,000 New Round 06/30/12 Boulder/Denver
Dyax, Adimab, Mersana, & More Boston Life Sciences Newsmakers 04/20/12 Boston
CoolChip, Copiun, Wingu Among the Slew of Boston Deals This Week 04/18/12 Boston
Alcresta Lands $10,000,000 Series A Round 04/18/12 Boston
Collegium Pharmaceutical Receives $22,500,000 New Funding Round 02/22/12 Boston
Biogen Buys Stromedix for $75M, Regaining Fibrosis Drug 02/14/12 Boston
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy 02/03/12 San Diego
Page 1 of 5 next page »